Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RALY antisense RNA 1 (RALY-AS1)
- Target
- RALY-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA, Natural antisense transcript (NAT), Cis-acting antisense RNA
01
Overview
RALY antisense RNA 1 (RALY-AS1) is a long non-coding RNA that is transcribed antisense to the RALY gene locus. Antisense RNAs such as RALY-AS1 regulate gene expression through diverse mechanisms, including repression of translation, alteration of chromatin structure, and modulation of transcriptional interference[2][3]. These RNAs are categorized as natural antisense transcripts (NATs); cis-acting NATs like RALY-AS1 are transcribed from the opposite strand of their target gene and often show high sequence complementarity, influencing the expression of the protein-coding gene at multiple stages[3]. While some antisense RNAs have roles in disease and gene imprinting, no direct molecular disease associations or drug interactions are currently described for RALY-AS1. The molecular function of RALY-AS1 specifically has not been extensively studied, and its involvement in disease processes or therapeutic modulation remains to be investigated.
- Other names
- RALY-AS1RALY antisense RNA 1
02
Biological functions
Regulation of gene expression (post-transcriptional and epigenetic)Possible involvement in transcriptional interferenceModulation of chromatin structureCould affect RNA splicing and stability of RALY mRNA (by analogy with other antisense RNAs)
Beyond the preview
Go deeper on RALY antisense RNA 1 (RALY-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RALY antisense RNA 1 (RALY-AS1).